Diagnosis and Treatment of Multiple Sclerosis: A Review MS is characterized by physical disability, cognitive impairment, and other symptoms that affect quality of life Treatment with DMT can reduce the annual relapse rate by 29% to 68% compared with placebo or active comparator
SciELO Brasil - Pattern of disease-modifying therapies use . . . McGinley MP, Goldschmidt CH, Rae-Grant AD Diagnosis and treatment of multiple sclerosis: A review JAMA 2021; 325 (8): 765-779 Polman H, O’Connor P, Havrdova E, Hutchinson M, Kappos L, Miller D, et al A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 2006; 354 (9): 899-910
Diagnosis and Treatment of Multiple Sclerosis: A Review. This review summarizes current evidence regarding diagnosis and treatment of multiple sclerosis and describes nine classes of disease-modifying therapies available for relapsing-remitting MS, defined as relapses at onset with stable neurologic disability between episodes Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Segurança e eficácia do tratamento medicamentoso da esclerose . . . Adaptada de McGinley MP, Goldschmidt CH, Rae-Grant AD Diagnosis and Treatment of Multiple Sclerosis: A Review JAMA 2021 Feb 23;325 (8):765-79 16 Linhas de tratamento da Esclerose Múltipla Remitente-Recorrente (EMRR) com DMDs no sistema público de saúde Figura 1 Algoritmo de tratamento da EM com DMDs no Sistema Único de